Rankings

The FDA has re­ject­ed spe­cial­ty phar­ma and gener­ics mak­er Am­neal Phar­ma­ceu­ti­cals’ ex­tend­ed-re­lease cap­sule for Parkin­son’s dis­ease, which com­bines two drugs that have long been used

HAMBURG, Germany — Smokers were more likely to have a specific metabolic signature that mediated their risk for developing type 2 diabetes, a researcher reported